EXUS
Price
$26.61Alerts
Change
+$0.38 (+1.45%)
Updated
Nov 11 closing price
Net Assets
87.66M
Intraday BUY SELL Signals
MELI
Price
$1512.02Alerts
Change
+$21.78 (+1.46%)
Updated
Nov 11 closing price
Capitalization
76.55B
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EXUS vs MELI

EXUS vs MELI Comparison Chart in %
View a ticker or compare two or three
VS
EXUS vs. MELI commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXUS is a Buy and MELI is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for EXUS with price predictions
Nov 11, 2026

EXUS's RSI Oscillator ascending out of oversold territory

The RSI Indicator for EXUS moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 7 similar instances when the indicator left oversold territory. In 7 of the 7 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for EXUS just turned positive on November 09, 2026. Looking at past instances where EXUS's MACD turned positive, the stock continued to rise in 12 of 14 cases over the following month. The odds of a continued upward trend are 86%.

Following a +3.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where EXUS advanced for three days, in 56 of 62 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

EXUS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EXUS as a result. In 20 of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for EXUS entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
a Summary for MELI with price predictions
Nov 11, 2026

MELI sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for MELI moved below the 200-day moving average on November 10, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MELI as a result. In 58 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for MELI turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 32 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

MELI moved below its 50-day moving average on October 21, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MELI crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 68%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MELI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

The Aroon Indicator for MELI entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MELI's RSI Indicator exited the oversold zone, 19 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +2.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where MELI advanced for three days, in 239 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

MELI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. MELI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.772) is normal, around the industry mean (22.398). MELI has a moderately high P/E Ratio (41.077) as compared to the industry average of (9.569). Projected Growth (PEG Ratio) (0.938) is also within normal values, averaging (1.774). Dividend Yield (0.000) settles around the average of (0.033) among similar stocks. P/S Ratio (2.651) is also within normal values, averaging (1.328).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MELI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

FUNDAMENTALS RATINGS
MELI: Fundamental Ratings
MELI
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
35
PRICE GROWTH RATING
1..100
75
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EXUSMELI
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 24 days ago
70%
Declines
ODDS (%)
Bearish Trend 14 days ago
82%
Bearish Trend 7 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
60%
View a ticker or compare two or three
Interact to see
Advertisement

EXUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXUS has been closely correlated with ASML. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if EXUS jumps, then ASML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXUS
1D Price
Change %
EXUS100%
+1.47%
ASML - EXUS
68%
Closely correlated
+1.76%
STM - EXUS
59%
Loosely correlated
+3.49%
EMBJ - EXUS
55%
Loosely correlated
-0.08%
MELI - EXUS
35%
Loosely correlated
+1.46%
ARGX - EXUS
27%
Poorly correlated
+0.62%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPRA15.930.36
+2.31%
Opera Limited
BCBP9.14-0.03
-0.33%
BCB Bancorp
BIRK36.61-0.66
-1.77%
Birkenstock Holding plc
PBR17.82-0.46
-2.52%
Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share)
RMTI7.08-0.23
-3.15%
Rockwell Medical Inc